Title : Development Of intravaginal liposomal gel of clomiphene citrate for treatment of polycystic ovary syndrome

Type of Material: Thesis
Title: Development Of intravaginal liposomal gel of clomiphene citrate for treatment of polycystic ovary syndrome
Researcher: Soni, Abhishek
Guide: Goyal, Sachin
Chaudhary, Amit
Department: School of Pharmacy
Publisher: Abhilashi University
Place: Mandi
Year: 2020
Language: English
Subject: Clinical Pre Clinical and Health
Pharmacology and Pharmacy
Pharmacology and Toxicology
Pharmacy
Medical and Health Sciences
Dissertation/Thesis Note: PhD
Fulltext: Shodhganga

00000000ntm a2200000ua 4500
001459821
003IN-AhILN
0052026-05-19 18:09:09
008__260519t2020||||ii#||||g|m||||||||||eng||
035__|a(IN-AhILN)th_459821
040__|dIN-AhILN|aABHI_175028
041__|aeng
100__|eResearcher|aSoni, Abhishek
110__|aSchool of Pharmacy|0U-0761|dMandi|bAbhilashi University|ein
245__|aDevelopment Of intravaginal liposomal gel of clomiphene citrate for treatment of polycystic ovary syndrome
260__|aMandi|c2020|bAbhilashi University
502__|bPhD
518__|d2020|oDate of Award
518__|oDate of Registration|d2016
518__|d2020|oDate of Completion
520__|aPolycystic ovary syndrome is one of the most common hormonal disorders among women ofreproductive age presenting with infertility. Due to its complex pathogenesis and unrecognized etiology, there is no effective preventive measure available for PCOS until now.The present study was to design and evaluate an intra-vaginal site-specific, liposomal gelcontaining clomiphene citrate, which can be targeted to the uterus (vagina) and time dependentmanner, to modulate the drug level in PCOS. Liposomes were prepared with LS75as phospholipid, Chloroform as the solvent, both Phospholipid and cholesterol in a ratio of0.02:0.01 at 600C temperature. Prepared liposomes were showed 80.303±0.199% drugentrapment efficiency. Liposomes were optimized using 3 level factorial designs whichpredicted the response 79.699%, whereas observed response was found 80.121% withpercentage error 0.299. Intravaginal gel was prepared with different concentrations ofcarbopol 934 and chitosan. Based on evaluation results CCG-3 formulation consi
650__|aPharmacy|2UGC
650__|aMedical and Health Sciences|2AIU
653__|aClinical Pre Clinical and Health
653__|aPharmacology and Pharmacy
653__|aPharmacology and Toxicology
700__|aGoyal, Sachin|eGuide
700__|aChaudhary, Amit|eGuide
856__|uhttp://shodhganga.inflibnet.ac.in/handle/10603/385311|yShodhganga
905__|afromsg

User Feedback Comes Under This section.